STEMNOVATE LIMITED
Company number 10140603 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£83,495
Balance sheet as at 2025-09-30
What it does
72110
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2016-04-22
- Employees
- 5 (2025 accounts · was 6 in 2024)
- Registered office
- Maia Building (270) Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT
- Postcode
- CB22 3AT
- Capital
- 13 GBP
- Accounts category
- Micro
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-09-30
- Next due by
- 2027-06-30
- Financial year end
- 30 September
Confirmation statement
- Last statement dated
- 2026-04-21
- Next due by
- 2027-05-05
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 3 resigned
DR Ruchi, Dr SHARMA
Director
DR David Colin, Dr HAY
Director
Contact details
- Website
- stemnovate.co.uk
- Phone
- 03031231113
Stemnovate page on drug discovery. The platforms provide solutions for next gen liver, heart and brain cell modelling.
Previous registered addresses 1
| Address | Changed on |
|---|---|
| CPC1 CAPITAL PARK FULBOURN, CAMBRIDGE, CAMBRIDGESHIRE, CB21 5XE, UNITED KINGDOM | 2017-11-14 |
Competitors Cambridge
This company ranks 196 among research and experimental development on biotechnology in Cambridge.
The class of 2016
36%
of the 402 companies in this sector incorporated in 2016 are still active today; 59% have since been dissolved.
A fact about the year, not a forecast for this company.